CCM
DGX icon

CrestPoint Capital Management’s Quest Diagnostics DGX Stock Holding History

CrestPoint Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2,900
Closed -$206K – 217
2015
Q4 		$206K Buy
+2,900
New +$195K 0.12% 185
2015
Q3 		– Sell
-3,200
Closed -$232K – 204
2015
Q2 		$232K Hold
3,200
– – 0.12% 207
2015
Q1 		$246K Hold
3,200
– – 0.13% 204
2014
Q4 		$215K Buy
+3,200
New +$202K 0.12% 215

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

CrestPoint Capital Management's DGX Position: Q1 2016 in Review

CrestPoint Capital Management sold out of Quest Diagnostics (DGX) in Q1 2016, closing a stake of 2,900 shares — an estimated $206K sold.

CrestPoint Capital Management first reported a position in DGX in Q4 2014 and held it in 4 quarters. The position peaked at $246K in Q1 2015. 557 funds tracked by Wall St. Rank hold DGX as of Q1 2016.

  • CrestPoint Capital Management reported no remaining Quest Diagnostics position as of Q1 2016 after selling out during the quarter.
  • CrestPoint Capital Management sold 2,900 Quest Diagnostics shares in Q1 2016, an estimated $206K.
  • CrestPoint Capital Management first reported a position in Quest Diagnostics in Q4 2014 and held it in 4 quarters.
  • CrestPoint Capital Management's Quest Diagnostics position peaked at $246K in Q1 2015.
  • 557 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2016.

Based on CrestPoint Capital Management's 13F filing for Q1 2016, filed 15 Apr 2016.